Model Number 3300TFX |
Device Problems
Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
|
Patient Problems
Endocarditis (1834); Sepsis (2067); Insufficient Information (4580)
|
Event Type
Injury
|
Manufacturer Narrative
|
H10: additional manufacturer narrative: the device was not returned for evaluation.Attempts to retrieve the device and additional information are in process.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Event Description
|
Edwards lifesciences maintains an implant patient registry (ipr).This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional "customer complaint".The information reported may or may not be related to the edwards device.It was reported via the implant patient registry that this valve model 3300tfx23mm implanted in aortic position was explanted from a 73 year old patient after an implant duration no longer than six (6) months and two (2) days for unknown reason.A 21mm surgical aortic valve was implanted in replacement.
|
|
Event Description
|
It was reported via the implant patient registry that this valve model 3300tfx23mm implanted in aortic position was explanted from a 73 year old patient after an implant duration of four (4) months and three (3) days due to endocarditis leading to annular abscess.The infecting organism was mssa (meticillin-sensitive staphylococcus aureus).Reportedly, the patient had cellulitis after electromyography (emg) and presented with sepsis.A 21mm surgical aortic valve was implanted in replacement.The patient was noted as to be discharged home.
|
|
Manufacturer Narrative
|
Added information to section d6 (explanted date).Updated section b4 (date of this report), b5 (describe event or problem), g3 (date received by manufacturer), h6 (device code(s)) and h6 (health effect - clinical code), h6 (investigation findings) and h6 (investigations conclusions).Corrected h6 (device code(s)) and h6 (health effect - clinical code).H10: additional manufacturer narrative: corrected data: initially, it was reported via the implant patient registry that this valve model 3300tfx23mm implanted in aortic position was explanted from a 73 year old patient after an implant duration no longer than six (6) months and two (2) days for unknown reason.A 21mm surgical aortic valve was implanted in replacement.However, through investigation it was learned that the valve was explanted from this patient after an implant duration of 4 months and 3 days due to endocarditis leading to annular abscess.Reportedly, the patient had cellulitis after electromyography (emg) and presented with sepsis.A valve model 3300tfx21mm was successfully implanted in replacement.The patient was noted as to be discharged home.Based on the additional information obtained, this event is no longer considered reportable and this correction is being submitted.
|
|
Search Alerts/Recalls
|
|